Dry January doesn't have to mean sober January — at least for the 21 percent of participants turning to cannabis or CBD to make it through the month.

According to a survey by Civic Science, 67 percent of Dry January participants, or those choosing to abstain from alcohol consumption for the month of January, reported they are replacing alcohol with something — whether that be mocktails and alcohol-free beers or sodas and seltzers.

The largest share, 21 percent, said they would enjoy cannabis or non-psychoactive CBD in place of alcohol. The preference for substitutes wasn't uniform across all respondents. Cannabis was the most popular substitute among the youngest respondents with 34 percent of 21- to 24-year-olds preferring it. Among the 55 and older crowd, by contrast, just 9 percent reported they'd enjoy cannabis or CBD instead of alcohol, and 54 percent reported they'd stay the course without any support.

Dry January's Growing Popularity

Interest in Dry January has climbed over the recent years. At the close of 2022, about 41 percent of respondents in a separate survey by Civic Science reported they were "somewhat to very likely" to participate in Dry January come 2023. That's in-line with pre-pandemic data for the start of 2020, but slightly behind 2022 responses, which rebounded after a lag in interest during the 2021 pandemic year.

As with the preference for cannabis, interest in Dry January tends to vary by age — and younger generations are leading the charge. For the year of 2023, more than half of the youngest respondents, aged 21 to 24 years old, said they were "somewhat to very likely" to participate versus just 41 percent of those 55 and older.

This trend among younger generations extends beyond January. Younger generations overall are less interested in alcohol. Although alcohol is still the most commonly reported substance used by young adults between 19 and 30 years old, the past-year, past-month, and daily alcohol use has declined over the last decade, according to an annual study from the National Institute on Drug Abuse (NIDA) and the University of Michigan. There has also been a spike in the use of substances like cannabis and psychedelics, although nowhere near to the extent of young peoples' alcohol consumption. 

Social Media Anxiety Fuels Sobriety

Studies suggest social media is contributing to a growing reluctance to drink with younger generations fearful of consequences if their drunk escapades are documented on the internet. According to 2019 research from Google, 49 percent of Generation Z reports their image online is "always at the back of their mind when they go out socializing and drinking." Some 76 percent reported it is important to have control of "all aspects of their life at all times," according to the research.

Share:
More In Science
FDA Panel Recommends Pfizer Vaccine for Kids Ages 5-11
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
A Look Ahead at G20 Summit and COP26 on Addressing the Climate Crisis
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Expanding Genetic Testing for Women Everywhere
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Proptech Startup Juno Raises $20 Million
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Innovation in Breast Cancer Screening
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
Merck to Offer Poorer Countries COVID-19 Pill Formula for Free
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Deal or No Deal, ISIS Threat & Memecoin Insanity
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
Load More